Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Stem Cell Procurement

Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis

A Corrigendum to this article was published on 04 June 2014

Abstract

HLA matching is a critical determinant of outcomes for patients who have undergone umbilical cord blood transplantation (UCBT). Data have been published on the importance of donor/recipient HLA mismatch direction on UCBT outcomes. HLA mismatch in the graft-versus-host (GVH) direction is defined as a donor homozygous at an HLA locus, while the recipient shares one HLA Ag with the donor. HLA mismatch in the host-versus-graft (HVG) direction is defined as a recipient homozygous with the donor sharing one HLA Ag. In our study we focused on confirming, using an independent population, whether transplantation outcomes would be different when HLA mismatch direction was considered. We analyzed 1565 patients who received a single-unit UCBT for malignant disease. Median age was 15 years and 72% of patients were transplanted for leukemia. In multivariate analysis, using the 5/6 HLA-matched population as reference, one or two HLA mismatches in the GVH or HVG direction were not associated with non-relapse related mortality and survival. On the basis of our results, there is no evidence to support a change in the current practice for cord blood unit selection.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Rocha V, Gluckman E . Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br J Haematol 2009; 147: 262–274.

    Article  CAS  PubMed  Google Scholar 

  2. Petersdorf EW . Optimal HLA matching in hematopoietic cell transplantation. Curr Opin Immunol 2008; 20: 588–593.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88: 795–802.

    CAS  PubMed  Google Scholar 

  4. Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Eng J Med 2000; 342: 1846–1854.

    Article  CAS  Google Scholar 

  5. MacMillan ML, Weisdorf DJ, Brunstein CG, Cao Q, DeFor TE, Verneris MR et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 2009; 113: 2410–2415.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. van Rood JJ, Stevens CE, Smits J, Carrier C, Carpenter C, Scaradavou A . Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies. Proc Natl Acad Sci USA 2009; 106: 19952–19957.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. van den Boogaardt DE, van Rood JJ, Roelen DL, Claas FH . The influence of inherited and noninherited parental antigens on outcome after transplantation. Transpl Int 2006; 19: 360–371.

    Article  CAS  PubMed  Google Scholar 

  8. Köegler G, Enczmann J, Rocha V, Gluckman E, Wernet P . High-resolution HLA typing sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant 2005; 36: 1033–1041.

    Article  Google Scholar 

  9. Matsuno N, Wake A, Uchida N, Ishiwata K, Araoka H, Takagi S et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood 2009; 114: 1689–1695.

    Article  CAS  PubMed  Google Scholar 

  10. Stevens CE, Carrier C, Carpenter C, Sung D, Scaradavou A . HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection. Blood 2011; 118: 3969–3978.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997; 15: 1767–1777.

    Article  CAS  PubMed  Google Scholar 

  12. Martin PJ, Weisdorf D, Przepiorka D, Hirschfeld S, Farrell A, Rizzo JD et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 2006; 12: 491–505.

    Article  PubMed  Google Scholar 

  13. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  PubMed  Google Scholar 

  14. Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.

    Article  Google Scholar 

  15. Fine JP, Gray RJ . A proportional hazards model for the sub distribution of a competing risk. J Am Stat Assoc 1999; 94: 496–499.

    Article  Google Scholar 

  16. Cox DR . Regression models and life tables. J R Stat Soc 1972; 34: 187.

    Google Scholar 

  17. Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan K-W et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397–407.

    Article  CAS  PubMed  Google Scholar 

  18. Eapen M, Klein J, Sanz GF, Spellman S, Ruggeri A, Anasetti C et al. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol 2011; 12: 1214–1221.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576–4583.

    Article  CAS  PubMed  Google Scholar 

  20. Loiseau P, Busson M, Balere M-L, Dormoy A, Bignon J-D, Gagne K et al. HLA association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1 or -DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant 2007; 13: 956–974.

    Article  Google Scholar 

  21. Kawase T, Morishima Y, Matsuo K, Kashiwase K, Inoko H, Saji H et al. High-risk HLA allele mismatch combinations responsible for severe acute graft versus host disease and implication for its molecular mechanism. Blood 2007; 110: 2235–2241.

    Article  CAS  PubMed  Google Scholar 

  22. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320: 197–204.

    Article  CAS  PubMed  Google Scholar 

  23. Takanashi M, Atsuta Y, Fujiwara K, Kodo H, Kai S, Sato H et al. The impact of anti-HLA antibodies on unrelated donor cord blood transplantations. Blood 2010; 116: 2839–2846.

    Article  CAS  PubMed  Google Scholar 

  24. Spellman S, Bray R, Rosen-Bronson S, Haagenson M, Klein J, Flesch S et al. The detection of donor-directed, HLA specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood 2010; 115: 2704–2708.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ciurea S, de Lima M, Cano P, Korbling M, Giralt S, Shpall EJ et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation 2009; 88: 1019–1024.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the following authors for contribution: W Arcese, B Rio, K Boudjedir and M Labopin. In addition, Fernanda Volt, Wagnara Chaves and Chantal Kenzey for help with data collection. Funded in part by the Inserm grant TGIR0805. V Rocha is funded by National Institute Health Research-Biomedical Research Centres (NIHR-BRC) funding scheme.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V Rocha.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Author contributions:

RC, PL, AR, EG and VR designed the study, prepared and analyzed data. ML analyzed data. RC, AR, EG and VR wrote the paper. GS, GM, API, GS, WA, AP, CDH, BR, FL, TOB, IY-A, MAD, NM, HB, MPS and DC provided cases for the study. RC, PL and KB prepared and verified data. All authors edited and approved the manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cunha, R., Loiseau, P., Ruggeri, A. et al. Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis. Bone Marrow Transplant 49, 24–29 (2014). https://doi.org/10.1038/bmt.2013.120

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2013.120

Keywords

This article is cited by

Search

Quick links